Stephen Silvestro

President & Chief Executive Officer, Optimizerx

Search every verified Stephen Silvestro interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In an October 2025 interview with Fierce Pharma, OptimizeRx CEO Stephen Silvestro discussed the shift in pharmaceutical marketing toward predictive analytics and real-time patient identification. He described the industry moving away from broad, untargeted campaigns toward AI and machine learning platforms that identify "brand-eligible" patients and coordinate messaging to both healthcare providers and patients simultaneously. Silvestro cited a project for a triple-negative breast cancer brand where the company's technology helped reduce time to therapy, noting that speed to treatment is a major factor in patient outcomes. Silvestro also addressed industry challenges, stating that marketers will need to make more data-driven decisions to remain accountable to investors and shareholders. He mentioned OptimizeRx's goal of becoming a "rule of 40" business and said the company is experiencing growth that the market is responding to positively. He characterized the use of funds for maximizing shareholder value and benefiting patients as not mutually exclusive.